Histopathologic evaluation of patients with liver-limited metastatic colorectal cancer receiving mFOLFOX6 plus bevacizumab or mFOLFOX6 plus cetuximab: The ATOM trial

Y. Emi, T. Yamanaka, K. Muro, H. Uetake, E. Oki, T. Takahashi, Y. Katayose, K. Yoshida, M. Sakamoto, S. Aishima, K. Ishida, J. Imura, M. Unno, I. Hyodo, N. Tomita, K. Sugihara, Y. Maehara

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)viii164
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Publication statusPublished - Oct 1 2018

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

Cite this